AEON AMEX
AEON Biopharma, Inc.
1W: -0.1%
1M: -2.8%
3M: -63.9%
YTD: -76.3%
1Y: -67.1%
3Y: -99.9%
$0.28
-0.01 (-3.79%)
Weekly Expected Move ±19.7%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
19 relationships19
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2023-01-11
Earliest Filing
2025-12-15
Latest Filing
investor: 15
partner: 2
target: 2
Counterparties (Filed by AEON)
19 relationshipsCompanies named in AEON's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Daewoong Pharmaceuticals, Co., LTD | — | investor | Counterparty in exchange agreement for convertible notes and warrants | 2025-12-15 | View |
| Aegis Capital Corp. | — | partner | Underwriter for the public offering of Common Units and Warrants. | 2025-01-07 | View |
| Daewoong Pharmaceutical Co., LTD. | — | investor | Investor in senior secured convertible notes and partner in license and supply agreement | 2024-03-19 | View |
| ACM ARRT J LLC | — | investor | Counterparty to terminated forward purchase agreement | 2024-03-19 | View |
| Polar Multi-Strategy Fund | — | investor | Counterparty to terminated forward purchase agreement | 2024-03-19 | View |
| Daewoong Co., LTD | — | investor | Investor in committed financing agreements and PIPE subscription | 2023-07-27 | View |
| Daewoong Pharmaceutical Co., Ltd. | — | investor | Investor in committed financing agreements and PIPE subscription | 2023-07-27 | View |
| Alphaeon 1, LLC | — | investor | Investor in committed financing agreements | 2023-07-27 | View |
| Strathspey Crown Holdings Group, LLC | — | investor | Investor in registration rights agreement and PIPE subscription | 2023-07-27 | View |
| ACM ARRT J LLC | — | investor | Investor in forward purchase agreements and PIPE subscription | 2023-07-27 | View |
| Polar Multi-Strategy Master Fund | — | investor | Investor in forward purchase agreements and PIPE subscription | 2023-07-27 | View |
| AEON Biopharma, Inc. | AEON | target | Target company in the business combination agreement with Priveterra Acquisition Corp. | 2023-06-30 | View |
| ACM ARRT J LLC | — | investor | Investor entering into Forward Purchase Agreement and PIPE Subscription Agreement. | 2023-06-30 | View |
| Polar Multi-Strategy Master Fund | — | investor | Investor entering into Forward Purchase Agreement and PIPE Subscription Agreement. | 2023-06-30 | View |
| Alphaeon 1 LLC | — | investor | Investor entering into Committed Financing Agreement for interim notes. | 2023-06-30 | View |
| Daewoong Pharmaceutical Co., Ltd. | — | investor | Investor entering into Committed Financing Agreement for interim notes. | 2023-06-30 | View |
| AEON Biopharma, Inc. | AEON | target | Target company in the business combination agreement with Priveterra Acquisition Corp. | 2023-05-01 | View |
| Priveterra Sponsor, LLC | — | investor | Sponsor entity entering into support agreements and receiving a promissory note. | 2023-05-01 | View |
| AEON Biopharma, Inc. | AEON | partner | Partnered with Priveterra to enter interim financing letter agreements for $20 million in connection with a Business Com | 2023-01-11 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-30 | Regulation FD; Other Events; Exhibits | View | |
| 2026-08-12 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-08-03 | Regulation FD; Other Events; Exhibits | View | |
| 2026-07-23 | Other Events | View | |
| 2026-07-15 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-06-17 | Shareholder Vote | View | |
| 2026-04-03 | Delisting Notice; Exhibits | View | |
| 2026-03-09 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-01-21 | Unregistered Sales of Equity Securities; Departure/Election of Directors; Appointment of Officers; S | View | |
| 2026-01-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-15 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-12-04 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-13 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-09-08 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-13 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-20 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-05-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-25 | Notice of Delisting or Transfer | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR